Page last updated: 2024-09-03

3-(n-maleimidopropionyl)biocytin and Cognition Disorders

3-(n-maleimidopropionyl)biocytin has been researched along with Cognition Disorders in 1 studies

*Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domino, EF; Kawamata, M; Nishiyama, S; Ohba, H; Takei, N; Tsukada, H; Wakuda, T; Yamamoto, S1

Other Studies

1 other study(ies) available for 3-(n-maleimidopropionyl)biocytin and Cognition Disorders

ArticleYear
Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:7

    Topics: Animals; Brain; Brain Mapping; Carbon Isotopes; Cognition Disorders; Consciousness; Disease Models, Animal; Dose-Response Relationship, Drug; Lysine; Macaca mulatta; Magnetic Resonance Imaging; Male; Maleimides; Muscarinic Antagonists; Neuropsychological Tests; Photic Stimulation; Positron-Emission Tomography; Reaction Time; Receptors, Muscarinic; Scopolamine; Time Factors

2011